Eye injection policy dropped after cost warnings - The Indian Sun

Government drops eye injection MBS changes following AMA concerns over patient costs

This week, we welcomed the federal government’s announcement that it will not proceed with the proposed private health insurance procedure type reclassification for some intravitreal eye injection (IVI) services under the Medicare Benefits Schedule (MBS). This proposed change related to IVI performed as an independent procedure without an anaesthetist (previously MBS item 42738, now MBS items 43030 and 43032) moving from Type B to Type C on 1 Ju…

Eye injection policy dropped after cost warnings - The Indian Sun

The Federal Government has withdrawn a planned policy change affecting sight saving eye injections, after warnings that patients could face higher out of pocket costs and reduced access to treatment. Private hospitals had raised concerns about the proposal to reclassify intravitreal eye injections under private health insurance rules. The change, originally scheduled to take effect on 1 July 2026, would have shifted the procedure from Type B to …